The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo

Molecular Therapy Nucleic Acids

Volumn 3, Issue , 2014, Pages e186-

  Lin, Su Ru ^a   Yang, Hung Chih ^a,b   Kuo, Yi Ting ^a   Liu, Chun Jen ^a,b   Yang, Ta Yu ^a   Sung, Ku Chun ^a   Lin, You Yu ^a,c   Wang, Hurng Yi ^a   Wang, Chih Chiang ^a   Shen, Yueh Chi ^a,b   Wu, Fang Yi ^a   Kao, Jia Horng ^a,b   Chen, Ding Shinn ^a,b   Chen, Pei Jer ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; COVALENTLY CLOSED CIRCULAR DNA; GUIDE RNA; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA TEMPLATE; EXPRESSION VECTOR; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS GENOTYPE A; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; INDEL MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; VIRUS GENOME; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DNA SEQUENCE; HEPATITIS B VIRUS; HUMAN; PROTEIN EXPRESSION; SOUTHERN BLOTTING;

EID: 84907379292     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2014.38     Document Type: Article

References (40)

1. Dandri, M, Burda, MR, Will, H and Petersen, J (2000). Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. Hepatology 32: 139-146.
2. Moraleda, G, Saputelli, J, Aldrich, CE, Averett, D, Condreay, L and Mason, WS (1997). Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 71: 9392-9399.
3. Tsiang, M, Rooney, JF, Toole, JJ and Gibbs, CS (1999). Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 29: 1863-1869.
4. Werle-Lapostolle, B, Bowden, S, Locarnini, S, Wursthorn, K, Petersen, J, Lau, G, et al. (2004). Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126: 1750-1758.
5. Caruntu, FA and Molagic, V (2005). CccDNA persistence during natural evolution of chronic VHB infection. Rom J Gastroenterol 14: 373-377.
6. Sung, JJ, Wong, ML, Bowden, S, Liew, CT, Hui, AY, Wong, VW et al. (2005). Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 128: 1890-1897.
7. Schiffer, JT, Swan, DA, Stone, D and Jerome, KR (2013). Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach. PLoS Comput Biol 9: e1003131.
8. Cradick, TJ, Keck, K, Bradshaw, S, Jamieson, AC and McCaffrey, AP (2010). Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther 18: 947-954.
9. Bloom, K, Ely, A, Mussolino, C, Cathomen, T and Arbuthnot, P (2013). Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 21: 1889-1897.
10. Chen, J, Zhang, W, Lin, J, Wang, F, Wu, M, Chen, C et al. (2014). An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases. Mol Ther 22: 303-311.
11. Bedell, VM, Wang, Y, Campbell, JM, Poshusta, TL, Starker, CG, Krug, RG 2nd et al. (2012). In vivo genome editing using a high-efficiency TALEN system. Nature 491: 114-118.
12. Gaj, T, Gersbach, CA and Barbas, CF 3rd (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31: 397-405.
13. Pan, Y, Xiao, L, Li, AS, Zhang, X, Sirois, P, Zhang, J et al. (2013). Biological and biomedical applications of engineered nucleases. Mol Biotechnol 55: 54-62.
14. Deveau, H, Garneau, JE and Moineau, S (2010). CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol 64: 475-493.
15. Bhaya, D, Davison, M and Barrangou, R (2011). CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet 45: 273-297.
16. Makarova, KS, Haft, DH, Barrangou, R, Brouns, SJ, Charpentier, E, Horvath, P et al. (2011). Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9: 467-477.
17. Wiedenheft, B, Sternberg, SH and Doudna, JA (2012). RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331-338.
18. Jinek, M, Chylinski, K, Fonfara, I, Hauer, M, Doudna, JA and Charpentier, E (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
19. Mali, P, Yang, L, Esvelt, KM, Aach, J, Guell, M, DiCarlo, JE et al. (2013). RNA-guided human genome engineering via Cas9. Science 339: 823-826.
20. Cong, L, Ran, FA, Cox, D, Lin, S, Barretto, R, Habib, N et al. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
21. Cho, SW, Kim, S, Kim, JM and Kim, JS (2013). Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 230-232.
22. Jinek, M, East, A, Cheng, A, Lin, S, Ma, E and Doudna, J (2013). RNA-programmed genome editing in human cells. Elife 2: e00471.
23. Friedland, AE, Tzur, YB, Esvelt, KM, Colaiácovo, MP, Church, GM and Calarco, JA (2013). Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10: 741-743.
24. Hwang, WY, Fu, Y, Reyon, D, Maeder, ML, Tsai, SQ, Sander, JD et al. (2013). Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31: 227-229.
25. Katic, I and Großhans, H (2013). Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans. Genetics 195: 1173-1176.
26. Wang, H, Yang, H, Shivalila, CS, Dawlaty, MM, Cheng, AW, Zhang, F et al. (2013). Onestep generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910-918.
27. Köck, J, Rösler, C, Zhang, JJ, Blum, HE, Nassal, M and Thoma, C (2010). Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathog 6: e1001082.
28. Huang, LR, Wu, HL, Chen, PJ and Chen, DS (2006). An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci USA 103: 17862-17867.
29. Li, F, Wei, H, Wei, H, Gao, Y, Xu, L, Yin, W et al. (2013). Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology 144: 392-401.
30. Cho, SW, Kim, S, Kim, Y, Kweon, J, Kim, HS, Bae, S et al. (2014). Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 24: 132-141.
31. Fu, Y, Foden, JA, Khayter, C, Maeder, ML, Reyon, D, Joung, JK et al. (2013). Highfrequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31: 822-826.
32. Ran, FA, Hsu, PD, Lin, CY, Gootenberg, JS, Konermann, S, Trevino, AE et al. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380-1389.
33. Mali, P, Aach, J, Stranges, PB, Esvelt, KM, Moosburner, M, Kosuri, S et al. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31: 833-838.
34. Levrero, M, Pollicino, T, Petersen, J, Belloni, L, Raimondo, G and Dandri, M (2009). Control of cccDNA function in hepatitis B virus infection. J Hepatol 51: 581-592.
35. Bi, Y, Sun, L, Gao, D, Ding, C, Li, Z, Li, Y et al. (2014). High-efficiency targeted editing of large viral genomes by RNA-guided nucleases. PLoS Pathog 10: e1004090.
36. Ebina, H, Misawa, N, Kanemura, Y and Koyanagi, Y (2013). Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3: 2510.
37. Hirt, B (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369.
38. Zhu, C, Gupta, A, Hall, VL, Rayla, AL, Christensen, RG, Dake, B et al. (2013). Using defined finger-finger interfaces as units of assembly for constructing zinc-finger nucleases. Nucleic Acids Res 41: 2455-2465.
39. Guschin, DY, Waite, AJ, Katibah, GE, Miller, JC, Holmes, MC and Rebar, EJ (2010). A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol 649: 247-256.
40. Ono, Y, Onda, H, Sasada, R, Igarashi, K, Sugino, Y and Nishioka, K (1983). The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 11: 1747-1757.